ENDRA Life Sciences Inc. (NDRA)
NDRA moved a median of -0.92% 30 minutes after news, and -1.51% by the close. How NDRA actually reacts to news — the realized, point-in-time move the market made, measured across 181 labeled events over the last three years with zero look-ahead.
NDRA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.01% | 31% | 154 |
| 30-min | -0.92% | 38% | 177 |
| 60-min | -0.79% | 39% | 179 |
| to close | -1.51% | 39% | 180 |
| Middle 50% of NDRA reactions | -3.93% to +2.01% |
|---|---|
| Median reaction (30-min) | -0.92% |
| Measured reactions | 181 |
Half of all ENDRA Life Sciences Inc. news events land between -3.93% and +2.01% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when NDRA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to NDRA's baseline. Nothing else.
Recent NDRA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form S-4 ENDRA Life Sciences Inc. | SEC filing · Form S-4 | SEC EDGAR | +0.00% | +1.68% | |
| Form 8-K ENDRA Life Sciences Inc. For: Oct 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.68% | |
| ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | Business Wire | +0.00% | +0.45% | |
| Form 8-K ENDRA Life Sciences Inc. For: Aug 17 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.27% | |
| Form 10-Q ENDRA Life Sciences Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.45% | |
| Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company | Press release | Business Wire | — | -3.11% | |
| Form 8-K ENDRA Life Sciences Inc. For: Jul 08 | SEC filing · Form 8-K | SEC EDGAR | -4.05% | +17.06% | |
| Form 8-K ENDRA Life Sciences Inc. For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | +11.86% | +11.63% | |
| ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing | Press release | Business Wire | -10.91% | -8.90% | |
| Form 8-K ENDRA Life Sciences Inc. For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | — | -26.50% | |
| NDRA Stock Alert: Halper Sadeh LLC is Investigating Whether ENDRA Life Sciences Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +1.49% | +6.44% | |
| Form 8-K ENDRA Life Sciences Inc. For: May 27 | SEC filing · Form 8-K | SEC EDGAR | -1.34% | -7.69% | |
| Form RW ENDRA Life Sciences Inc. | SEC filing · Form RW | SEC EDGAR | — | +5.10% | |
| ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | Business Wire | -0.60% | +8.20% | |
| Form 10-Q ENDRA Life Sciences Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.60% | +8.20% | |
| Form S-8 ENDRA Life Sciences Inc. | SEC filing · Form S-8 | SEC EDGAR | -0.60% | +8.20% | |
| ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility | Press release | Business Wire | +0.80% | +1.41% | |
| Form 8-K ENDRA Life Sciences Inc. For: Apr 20 | SEC filing · Form 8-K | SEC EDGAR | -4.68% | -13.54% | |
| ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | Press release | Business Wire | +0.00% | +5.92% | |
| Form 10-K ENDRA Life Sciences Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +5.92% | |
| Form 8-K ENDRA Life Sciences Inc. For: Mar 31 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.92% | |
| ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value | Press release | Business Wire | -2.42% | +13.64% | |
| Form 8-K ENDRA Life Sciences Inc. For: Mar 19 | SEC filing · Form 8-K | SEC EDGAR | -2.42% | +13.64% | |
| ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care | Press release | Business Wire | +2.38% | -6.67% | |
| Form 8-K ENDRA Life Sciences Inc. For: Dec 09 | SEC filing · Form 8-K | SEC EDGAR | -1.51% | +0.00% | |
| ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use | Press release | Business Wire | +1.13% | +3.77% | |
| Form 8-K ENDRA Life Sciences Inc. For: Nov 28 | SEC filing · Form 8-K | SEC EDGAR | -2.19% | -1.83% | |
| ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker | Press release | Business Wire | -0.44% | -12.83% | |
| ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results | Press release | Business Wire | +0.00% | -10.02% | |
| Form 10-Q ENDRA Life Sciences Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -10.02% | |
| Form 8-K ENDRA Life Sciences Inc. For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -10.02% | |
| ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA | Press release | Business Wire | +0.16% | — | |
| Form S-3 ENDRA Life Sciences Inc. | SEC filing · Form S-3 | SEC EDGAR | -0.35% | -9.45% | |
| Form 8-K ENDRA Life Sciences Inc. For: Oct 29 | SEC filing · Form 8-K | SEC EDGAR | +0.51% | -1.41% | |
| Form ARS ENDRA Life Sciences Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.00% | -2.67% | |
| Form DEF 14A ENDRA Life Sciences Inc. For: Dec 31 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -2.67% | |
| Form DEFA14A ENDRA Life Sciences Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -2.67% | |
| Form D ENDRA Life Sciences Inc. | SEC filing · Form D | SEC EDGAR | +0.00% | -0.38% | |
| ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings | Press release | Business Wire | -1.64% | +1.43% | |
| Form 8-K ENDRA Life Sciences Inc. For: Oct 23 | SEC filing · Form 8-K | SEC EDGAR | -1.64% | +1.43% | |
| Form PRE 14A ENDRA Life Sciences Inc. For: Dec 31 | SEC filing · Form PRE | SEC EDGAR | +0.00% | +2.93% | |
| Form 8-K ENDRA Life Sciences Inc. For: Oct 10 | SEC filing · Form 8-K | SEC EDGAR | +0.28% | +4.22% | |
| Form 8-K/A ENDRA Life Sciences Inc. For: Oct 10 | SEC filing · Form 8-K | SEC EDGAR | -1.70% | -5.53% | |
| ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca | Press release | Business Wire | -11.49% | -17.40% | |
| ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results | Press release | Business Wire | +0.00% | +6.35% | |
| Form 10-Q ENDRA Life Sciences Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +6.35% | |
| Form S-1/A ENDRA Life Sciences Inc. | SEC filing · Form S-1 | SEC EDGAR | -0.52% | -2.51% | |
| Form 8-K ENDRA Life Sciences Inc. For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | -1.02% | +1.02% | |
| Form S-1/A ENDRA Life Sciences Inc. | SEC filing · Form S-1 | SEC EDGAR | -0.13% | -8.71% | |
| Form 8-K ENDRA Life Sciences Inc. For: Jul 09 | SEC filing · Form 8-K | SEC EDGAR | +0.99% | -0.87% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the NDRA section they belong to.
Where else NDRA is measured.
NDRA earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | 183 | -0.30% | 43% |
| ELEKTA B SHS UNSP/ADR (EKTAY) | 182 | 0.00% | 17% |
| Cocrystal Pharma, Inc. (COCP) | 180 | 0.00% | 48% |
| BIO BLAST PHARMA LTD ORDINARY (ORPN) | 180 | 0.00% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is ENDRA Life Sciences Inc.'s median reaction calculated?
Every labeled NDRA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 181 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 38% of NDRA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does NDRA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.